Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hear+Hi is a hearing health company focused on consumer assistive hearing devices for people with mild to moderate hearing loss. The business operates as a wholly owned subsidiary of GMEMS Technologies and was founded in 2020 to bring hearing-health hearables to market. Its products combine wireless audio hardware with digital signal processing, noise reduction, and smartphone-based personalization through the My Hearing Acuity app. Hear+Hi appears to be a commercial-stage medical device and digital hearing company rather than a therapeutics developer, with offerings such as Acuity-branded amplified earphones and true wireless earbuds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hear+Hi.